Log In
Sign Up
Romania
Citizenship:
Ph.D. degree award:
Andreea Letitia
Arsene
Professor
-
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"
Other affiliations
Clinical pharmacist
-
INSTITUTUL DE PNEUMOFTIZIOLOGIE "MARIUS NASTA"
(
Romania
)
Researcher | Teaching staff | Scientific reviewer | PhD supervisor
>20
years
Personal public profile link.
Expertise & keywords
Clinical pharmacy
Clinical biochemistry
Microbiology
Molecular biology
Projects
Publications & Patents
Entrepreneurship
Reviewer section
Supporting CDI excellence in the Health Sector and increasing the competitiveness of the "Carol Davila" University of Medicine and Pharmacy in Bucharest to achieve European Regional Leader Status
Call name:
2021
-
2024
Role in this project:
Key expert
Coordinating institution:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"
Project partners:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Affiliation:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Project website:
Abstract:
Read more
European Network to Advance Best practices & technoLogy on medication adherencE, COST action 19132
Call name:
2020
-
2022
Role in this project:
Key expert
Coordinating institution:
COST Association
Project partners:
COST Association ()
Affiliation:
COST Association ()
Project website:
Abstract:
Read more
Optimizing the institutional mechanisms for correlating the educational supply with the labor market demand. Targeted area: 7. Correlation of the educational offer with the demand of the labor market, counseling and career guidance
Call name:
2021
-
2021
Role in this project:
Key expert
Coordinating institution:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"
Project partners:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Affiliation:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Project website:
Abstract:
Read more
New methods of pregnancy monitoring and prenatal diagnosis
Call name:
P 1 - SP 1.2 - Proiecte complexe realizate in consorții CDI
PN-III-P1-1.2-PCCDI-2017-0820
2018
-
2021
Role in this project:
Coordinating institution:
INSTITUTUL NATIONAL DE CERCETARE- DEZVOLTARE PENTRU MICROTEHNOLOGIE - IMT BUCURESTI INCD
Project partners:
INSTITUTUL NATIONAL DE CERCETARE- DEZVOLTARE PENTRU MICROTEHNOLOGIE - IMT BUCURESTI INCD (RO); UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" (RO); INSTITUTUL CLINIC FUNDENI (RO); INSTITUTUL NATIONAL PENTRU SANATATEA MAMEI SI COPILULUI "ALESSANDRESCU-RUSESCU" BUCURESTI (RO); UNIVERSITATEA POLITEHNICA DIN BUCURESTI (RO)
Affiliation:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" (RO)
Project website:
https://www.imt.ro/mimosa/
Abstract:
The Complex Project „ New methods of pregnancy monitoring and prenatal diagnosis” proposes to define and develop new biomedical devices for pregnant women and foetus monitoring, with the purpose to avoid life-threating complications for both the mother and the child.
It will be developed through four Component Projects:
1. Prenatal non-invasive screening, using cell free fetal DNA, extracted from the mother’s blood. It will develop a chip for the non-invasive detection of the SRY gene, together with a working protocol for a new type of non-invasive analysis for the early prenatal diagnosis.
2. Non-invasive microsensors for continuous glucose monitoring during pregnancy – proposes the technology development for a non-invasive glucose sensor to measure the glucose level in saliva. The project will support the continuous monitoring of pregnant women, avoiding dangers effects coming from the invasive methods (inflammations, infections).
3. Evaluation of premature birth risks due to the HPV-EVA-RINA infection. The project will develop clinical studies related to the HPC infection involvement in triggering premature birth, using genotyping microarray-type structures;
4. Wireless multi-sensor system for foetal activity and uterine contractions monitoring and classification during pregnancy – aims to develop an intelligent system, containing a wireless network of wearable sensors and a main unit for signal processing and analysis.
The complex project description includes the novelty elements, detailed activities description, the working procedures within the consortium, expected results and deliverables. The deliverables has an average TRL 5, which means all four component projects will have a high technological level and the result’s maturity will reach at least successful laboratory testing.
Read more
Experimental studies on the implications of the microbiota in identifying the risk of endocrine dysfunctions
Call name:
2019
-
2020
Role in this project:
Project coordinator
Coordinating institution:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"
Project partners:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Affiliation:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Project website:
Abstract:
Read more
IMPROVEMENT OF INTERDISCIPLINARY RESEARCH TEAMS FOR OPTIMIZATION OF EXPERIMENTAL/FUNCTIONAL MODELS IN MEDICINAL SCIENCE SUBFIELD
Call name:
2018
-
2018
Role in this project:
Key expert
Coordinating institution:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"
Project partners:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Affiliation:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Project website:
Abstract:
Read more
OPTIMIZATION OF THE MODERN TECHNOLOGY FOR PROCESSING BREWING SPENT YEAST AND OBTAINING OF DERIVED PRODUCTS
Call name:
P 2 - SP 2.1 - Transfer de cunoaștere la agentul economic „Bridge Grant”
PN-III-P2-2.1-BG-2016-0308
2016
-
2018
Role in this project:
Coordinating institution:
UNIVERSITATEA DE STIINTE AGRONOMICE SI MEDICINA VETERINARA
Project partners:
UNIVERSITATEA DE STIINTE AGRONOMICE SI MEDICINA VETERINARA (RO); INSTITUTUL NATIONAL DE CERCETARE-DEZVOLTARE PENTRU TEXTILE SI PIELARIE - INCDTP BUCURESTI (RO); UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO); PHARMACORP INNOVATION S.R.L. (RO); UNIVERSITATEA POLITEHNICA DIN BUCURESTI (RO); AGSIRA SRL (RO)
Affiliation:
UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO)
Project website:
http://www.usamv.ro/dgpcsa-cdi/optimizarea-tehnologiei-moderne-de-procesare-drojdiei-uzate-de-bere-si-de-obtinere-produselor-derivate-biodryyeast/
Abstract:
The consortium consists of five research organizations that aim to obtain new products through optimization and validation of technologies, as well as to provide recommendation for the modernization of the existing production lines. The main objective of the industrial producer AGSIRA is to provide at least one new product to existing customers.
The research organizations will tackle together with AGSIRA the following issues established based on the needs identified at the industrial producer:
-design of a new production line to produce brewing yeast as feed through a new biotechnological process;
-obtaining a new product, having superior quality in comparison with the existing product in terms of composition, by optimizing the mixture between the yeast produced by the new technology with current processed spent brewing yeast;
-obtaining active brewing yeast (by freeze-drying and atomization);
-obtaining of derived products based on brewing yeast.
Read more
DESIGN, EVALUATION AND MODELING OF DRUG RELEASE MECHANISM FOR NOVEL TOPICAL MULTIPARTICULATE DELIVERY SYSTEMS
Call name:
P 2 - SP 2.1 - Proiect experimental - demonstrativ
PN-III-P2-2.1-PED-2016-0813
2017
-
2018
Role in this project:
Coordinating institution:
UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA
Project partners:
UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO); INSTITUTUL NATIONAL DE CERCETARE-DEZVOLTARE PENTRU TEXTILE SI PIELARIE - INCDTP BUCURESTI (RO)
Affiliation:
UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO)
Project website:
https://umfcd.ro/cercetare-si-dezvoltare/proiecte/proiecte-nationale/proectarea-evaluarea-si-modelarea-mecanismului-de-eliberare-a-medicamentului-pentru-noi-sisteme-multiparticulate-de-cedare-topica/
Abstract:
TOPMULTINOV project is a new and modern concept for the development of smart biomaterial supports usable in burned skin repair. Efficient regeneration of burned skin is still a clinical challenge, obtaining of an adequate drug release support being a top approach in the field of biomaterials. The general objective of this project consists of the design, evaluation and modeling of an anti-inflammatory drug release mechanism from topical multiparticulate systems that will ensure a controlled release for burns healing. As a novelty element of the project, ensuring a proper anti-inflammatory drug delivery from spongious collagen-based supports using different techniques that allow a gradual degradation of collagen support and a slow release of drug is mentioned. The vehicle formulation in the drug delivery sciences is a critical quality attribute which needs special attention for tailor made design to rationalize the system development. Thus, the project presents a new approach concerning the preparation of release supports like collagen-based spongious matrices with an anti-inflammatory drug incorporated in free form, in free and encapsulated form, and in encapsulated form respectively, to model and control its release rate. The results generated by the preparation, physico-chemical and morphological characterization as well as the in vitro studies of drug release and testing of the designed topical systems on animal model will be disseminated at conferences, in specialty articles, and by patent application. The pluridisciplinarity and complementarity of both teams provide high level of scientific/technical experiences to ensure a successful project achievement. TOPMULTINOV is perfectly integrated in the national and European strategies with respect to the impact on human health for improved health and life quality.
Read more
INNOVATIVE THERAPEUTIC PRODUCTS WITH PROPHILACTIC AND CURATIVE ACTION FOR ZOO-VETERINARY SECTOR
Call name:
Joint Applied Research Projects - PCCA 2013 - call
PN-II-PT-PCCA-2013-4-0953
2014
-
2017
Role in this project:
Coordinating institution:
UNIVERSITATEA DE STIINTE AGRONOMICE SI MEDICINA VETERINARA
Project partners:
UNIVERSITATEA DE STIINTE AGRONOMICE SI MEDICINA VETERINARA (RO); UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO); ASOCIATIA CENTRU DE CERCETARE STIINTIFICA IN DOMENIUL BIOCHIMIEI APLICATE SI BIOTEHNOLOGIEI (BIOTEHNOL) (RO); BIOING S.A. (RO); HOFIGAL EXPORT IMPORT SA (RO)
Affiliation:
UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO)
Project website:
http://sanovet.fifim.ro/
Abstract:
Title: „INNOVATIVE THERAPEUTIC PRODUCTS WITH PROPHILACTIC AND CURATIVE ACTION FOR ZOO-VETERINARY SECTOR”
Acronym: SANOVET
Program: PARTNERSHIPS
Subprogram: “ Applied Collaborative Research Projects”
Domain 5 - Agriculture, food safety and security
Research thematic: 5.1.4. Methods, techniques and technologies for growth and diversification of animal production and fisheries, veterinary protection insurance Animal health is a concern for all European citizens. This concern stems from the public health, food safety and food security aspects, which are related to animal health but also to economic costs that animal disease outbreaks can trigger. This project uses a very common and a high economical and ecologically impact disease model like inflammation, as a paradigm for a conceptual and practical approach aimed to capitalize inexpensive and available resources.
The project goal is to improve the level of veterinary protection by developing a semi - solid phytoproduct from indigenous flora with topical application.
Main objectives that will ensure the achievement of project aim are:
1. Obtaining crops to exploit the curative potential of Anthriscus sp.;
2. Obtaining the phytocomplex;
3. Evaluating extracts pharmacological viability;
4. Obtaining an innovative phytoproduct .
The results of this research project will be materialized through:
1. Development and characterization of a herbal extract enriched in active ingredients with a complex chemical structure, non-toxic, based on original recipe obtained from association of fractionated extract with volatile oil from Anethum sp properly processed,
2. Highlighting the biologic activity, which plays a role in sustaining and accelerating the healing process by in vivo testing of herbal extract,
3. Creating a new topic semisolid phytoproduct.
The project addresses to a major agricultural problem in an interdisciplinary aggregate approach in order to achieve high yields results with a low economical input and a great environmental safety.
Read more
Development of a herbal medicinal product with topical administration in allergic dermatitides
Call name:
Joint Applied Research Projects - PCCA 2013 - call
PN-II-PT-PCCA-2013-4-1953
2014
-
2017
Role in this project:
Coordinating institution:
UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA
Project partners:
UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO); HOFIGAL EXPORT IMPORT SA (RO); AGROECO BIOTERRA SRL (RO); UNIVERSITATEA DE STIINTE AGRONOMICE SI MEDICINA VETERINARA (RO)
Affiliation:
UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO)
Project website:
http://www.umfcaroldavila.ro/index.php/activitatea-stiintifica/programe-pnii/1176-dezvoltarea-unui-medicament-pe-baza-de-plante-cu-administrare-topica-in-dermatoze-alergice
Abstract:
Immunological dysfunctions with cutaneous manifestations, such as urticaria, contact dermatitis or atopical dermatitis are social problems affecting a considerable part of the population, especially in the developed countries. Adverse effects accompanying the topical treatment with the current medicinal products limit their use for all the patients. Through this project we aim at developing and obtaining by technologies an original product – a herbal medicinal product of topical use intended in the treatment of cutaneous conditions mediated immunologically, thus contributing to the increase of the quality of life of the affected patients. The product will ensure the treatment of pathologies affecting a high number of patients, both at the national and international level. Although the herbal material initially used to define the standardized extract will be derived from ecological cultures (the risk of contamination with chemical allergenes being non-existent), the final objective is its production through biotechnologies, so as to allow the obtaining of the active raw material in appropriate amounts, of acceptable purity and independently of the seasonal cultures.
For this purpose the content in biocompounds with antiallergic potential activity from 10 herbal species (Morus alba L., Amaranthus caudatus L., Sambucus nigra L., Rubus idaeus L., Momordica charantia Descourt., Plantago lanceolata L., Ribes nigrum L., Rubia tinctorum L., Cynara scolymus L., Achillea millefolium L.) will be explored, as well as their correlation with the antiallergic activity (also at immunological level), for their later purification and obtaining of the pharmaceutical active extract. This will ensure the identification of the species, extract and fraction with the highest efficacy (in the indication of interest – allergies which may be treated topically) and safety proven in preclinical models. A biotechnology (cultures of plant tissues) of obtaining the active component of a topical medicinal product with antiallergic activity, identified based on the pharmacological and biochemical data and the variables affecting qualitatively and quantitatively the characteristics of the biomass obtained in the tissue culture, including the composition in active principles of interest, will be assessed. This will allow optimisation of the biotechnological process of obtaining the standardized extract that will constitute the active substance of the medicinal product for topical use.
Until now, no scientific study has reported the investigation of the antiallergic activity at topical level of purified extracts from these species or has examined the correlation of such an activity with the imunological effects and the classes of phytochemicals responsible for this activity. On the Romanian market several products of herbal nature are marketed in this therapeutical area, but they have not been developed scientifically and are not authorized as medicinal products (being not listed in the official Register drawn out by the National Agency for Medicines and Medical Devices), but (probably) as medical devices, which means that they act mainly through a mechanical effect, of barrier or by ensuring hydration, but not by an anti-inflammatory/antiallergic activity proper, of a pharmacological nature.
The project will be realized by the collaboration of three partners: The University of Medicine and Pharmacy “Carol Davila” Bucharest (with a multidisciplinary team of experts in pharmaceutical botany, phytochemistry, pharmacology, biochemistry, pharmaceutical chemistry, physical chemistry and pharmaceutical technology), the University of Agronomical Sciences and Veterinary Medicine Bucharest (with a team of experts in the field of biotechnology), SC Hofigal Export Import (one of the most important producers of medicines of herbal origin on the Romanian market) and SC Agroeco Biottera SRL (a company specialized in the ecological cultivation of herbal medicinal species).
Read more
Design and development of transport and delivery systems for new ruthenium compunds with antitumor activity
Call name:
Joint Applied Research Projects - PCCA-2011 call, Type 2
PN-II-PT-PCCA-2011-3.2-1454
2012
-
2016
Role in this project:
Coordinating institution:
UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA
Project partners:
UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO); INSTITUTUL ONCOLOGIC PROF.DR.ALEXANDRU TRESTIOREANU BUCURESTI (RO); UNIVERSITATEA BUCURESTI (RO); INSTITUTUL DE VIRUSOLOGIE "STEFAN S.NICOLAU" (RO); PHARMA SERV INTERNATIONAL SRL (RO)
Affiliation:
UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO)
Project website:
http://cercetare-umf.ro/uploads_ro/592/Pagina_web_136_2012-actualizata_2016.pdf
Abstract:
The proposed cooperative study is a complex interdisciplinary approach aimed at developing pharmaceutical product models with significant antitumor action and minimal side effects. During the project, three pharmaceutical systems that include some ruthenium complexes will be studied regarding solubility, capacity to transport and deliver the active substance at the final site of action, the antitumor activity and the side effects. The final scope of the project is to select the system (or systems) who best meet the requirements regarding bioavailability and pharmaco-toxicological properties for a possible inclusion in the clinical trials of the studied ruthenium complexes.
The proposed project has least three main goals. First, we want to develop pharmaceutical systems for improve the solubility of some ruthenium compounds in order to achieve a better pharmacokinetic profile for these compounds. Second, we intend to evaluate the antitumor activity of the developed systems using various cell lines from solid tumors and in vivo, comparing to cisplatin as reference substance. Third, we intend to evaluate the general toxicity of the developed systems, comparing to cisplatin. Additionally, we want to explore the possibility of development of these products as oral drugs and to establish what kind of cancer can be treated with these agents.
Read more
EFFICIENCY OF PHARMACIST ACTIVITY THROUGH TRAINING IN NEW TECHNOLOGIES, INCLUDING ICT
Call name:
2010
-
2012
Role in this project:
Key expert
Coordinating institution:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"
Project partners:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Affiliation:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Project website:
Abstract:
Read more
THE PHARMACOKINETIC AND CLINICAL IMPACT OF NEUROENDOCRINE FACTORS IN THERAPY WITH ATYPICAL ANTIPSYCHOTICS
Call name:
2008
-
2011
Role in this project:
Key expert
Coordinating institution:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"
Project partners:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Affiliation:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Project website:
Abstract:
Read more
THE DEVELOPMENT OF SOME INNOVATIVE METHODS FOR RESEARCHING THE MECHANISMS OF ACTION AND EARLY ASSESSMENT OF THE TOXICITY OF IMMUNOSUPPRESSING THERAPIES IN SOME AUTOIMMUNE RHEUMATIC DISEASES
Call name:
2008
-
2011
Role in this project:
Key expert
Coordinating institution:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"
Project partners:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Affiliation:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Project website:
Abstract:
Read more
BIOPHARMACEUTICAL CRITERIA FOR OPTIMIZING THE SAFETY AND EFFECTIVENESS PROFILE FOR HYDROPHOBIC MEDICINES
Call name:
2008
-
2011
Role in this project:
Key expert
Coordinating institution:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"
Project partners:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Affiliation:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Project website:
Abstract:
Read more
SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF NEW COMPOUNDS FOR THE IMPLEMENTATION OF MODERN THERAPIES IN THE TREATMENT OF OBESITY AND/OR TYPE 2 DIABETES: PREPARATORY RESEARCH, STRUCTURE, PHARMACOLOGICAL SCREENING
Call name:
2008
-
2011
Role in this project:
Key expert
Coordinating institution:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"
Project partners:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Affiliation:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Project website:
Abstract:
Read more
Synthesis, characterization and testing of biological activity of some new ruthenium complexes, potential alternative to platinum therapy
Call name:
PNII 61-048/2007
2007
-
2010
Role in this project:
Key expert
Coordinating institution:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"
Project partners:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Affiliation:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Project website:
Abstract:
Read more
Development of a QSAR bioinformatic sistem for modeling of antitumoral and antirheumatic therapeutic agents in individualized therapies
Call name:
61-037/2007
2007
-
2010
Role in this project:
Key expert
Coordinating institution:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"
Project partners:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" (); INSTITUTUL NATIONAL DE CERCETARE-DEZVOLTARE IN DOMENIUL PATOLOGIEI SI STIINTELOR BIOMEDICALE "VICTOR BABES" (); UNIVERSITATEA BUCURESTI (); TERRASIGNA SRL ()
Affiliation:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Project website:
http://bioinfoqsar.asrc.ro/
Abstract:
Read more
CELLULAR AND SUBCELLULAR EFFECTS OF SOME NATURAL ANTIOXIDANTS IN NORMAL AND STRESS CONDITIONS
Call name:
2006
-
2009
Role in this project:
Key expert
Coordinating institution:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"
Project partners:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Affiliation:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Project website:
Abstract:
Read more
THE USE OF COMPOUNDS LABELED WITH RADIOACTIVE ISOTOPES IN MOLECULAR BIOLOGY, PHARMACOLOGY AND TOXICOLOGY STUDIES
Call name:
2005
-
2007
Role in this project:
Key expert
Coordinating institution:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"
Project partners:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Affiliation:
UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" ()
Project website:
Abstract:
Read more
Contract CEEX nr. 51/2005 “New structures with possible action antidiabetic/against obesity beta agonist receptors–3-adrenergics multidisciplinars researches” (VIASAN), Responsabile partener 2 UB, 2005-2007.
Call name:
2005
-
2007
Role in this project:
Key expert
Coordinating institution:
UNIVERSITATEA BUCURESTI
Project partners:
UNIVERSITATEA BUCURESTI ()
Affiliation:
UNIVERSITATEA BUCURESTI ()
Project website:
Abstract:
Read more
FILE DESCRIPTION
DOCUMENT
List of research grants as project coordinator or partner team leader
Significant R&D projects for enterprises, as project manager
R&D activities in enterprises
Peer-review activity for international programs/projects
[T: 0.3628, O: 424]